GET LINCKR

Citryll Company Contacts

Citryll

http://www.citryll.com
Citryll has translated a deep understanding of the neutrophil extracellular trap (NET) pathway to therapeutically address its central role in a broad range of inflammatory diseases. With a unique dual mode of action, the company’s lead antibody, CIT-013, has reached... Read More
Contacts

Country

Netherlands

City

Oss

Headquarters

Oss, Noord-Brabant

LinkedIn

Profile

Founded

2015

Industry

Biotechnology Research

Size

11 - 50

Specialties

Immunology, Therapeutics development, Neutrophil Extracellular Traps, Inflammatory diseases, Antibody development, Rheumatoid Arthritis, Hidradenitis Suppurativa

Funding

Total Rounds

2

Last Round

Wed Jul 01 2020

Last Round Series

Series B

Last Round Raised

$ 20,789,437